SCHEMBL6180846

SCHEMBL6180846

CC(C)(C)OC(=O)NC1CN(C(=O)C2CCN(C(=O)OCc3ccccc3)CC2)c2ccccc2NC1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
HTT P42858 1/20 0.46
MAPK1 P28482 3/20 0.45
GAA P10253 1/20 0.45
CYP2C19 P33261 1/20 0.45
P2RX7 Q99572 2/20 0.42
PDE4B Q07343 1/20 0.42
STS P08842 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
MAPT P10636 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
NTSR1 P30989 1/20 0.40
ENPP2 Q13822 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39
PARP1 P09874 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6179135 0.86 CTSK (0.47) SMN1; SMN2NPC1RAB9AMAPK1GAA
SCHEMBL6177679 0.86 CTSK (0.47) SMN1; SMN2NPC1RAB9AMAPK1GAA
SCHEMBL6175840 0.85 EPHX2 (0.45) GAA
SCHEMBL6180290 0.85 CTSK (0.48) SMN1; SMN2NPC1RAB9AMAPK1GAA
SCHEMBL6178399 0.83 EPHX2 (0.43) GAAL3MBTL1MAPTALDH1A1KMT2A
SCHEMBL6176160 0.83 IDH1 (0.45) GAAL3MBTL1MAPTALDH1A1POLB
SCHEMBL4988641 0.82 NPC1 (0.46) SMN1; SMN2NPC1RAB9AMAPK1GAA
SCHEMBL4988629 0.82 NPC1 (0.46) SMN1; SMN2NPC1RAB9AMAPK1GAA
SCHEMBL6178514 0.81 GAA (0.47) SMN1; SMN2NPC1RAB9AMAPK1GAA
SCHEMBL7959365 0.80 NPC1 (0.43) SMN1; SMN2NPC1RAB9AMAPK1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0945445-B9 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2005-12-28 EP disclosed
EP-0945445-B1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2003-09-03 EP disclosed
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed
EP-0945445-A1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-09-29 EP disclosed